Timing of Novel Drug 1A-116 to Circadian Rhythms Improves Therapeutic Effects against Glioblastoma
- Supplementary File 1:
ZIP-Document (ZIP, 1003 KiB)
Trebucq, L.L.; Cardama, G.A.; Lorenzano Menna, P.; Golombek, D.A.; Chiesa, J.J.; Marpegan, L. Timing of Novel Drug 1A-116 to Circadian Rhythms Improves Therapeutic Effects against Glioblastoma. Pharmaceutics 2021, 13, 1091. https://doi.org/10.3390/pharmaceutics13071091
Trebucq LL, Cardama GA, Lorenzano Menna P, Golombek DA, Chiesa JJ, Marpegan L. Timing of Novel Drug 1A-116 to Circadian Rhythms Improves Therapeutic Effects against Glioblastoma. Pharmaceutics. 2021; 13(7):1091. https://doi.org/10.3390/pharmaceutics13071091
Chicago/Turabian StyleTrebucq, Laura Lucía, Georgina Alexandra Cardama, Pablo Lorenzano Menna, Diego Andrés Golombek, Juan José Chiesa, and Luciano Marpegan. 2021. "Timing of Novel Drug 1A-116 to Circadian Rhythms Improves Therapeutic Effects against Glioblastoma" Pharmaceutics 13, no. 7: 1091. https://doi.org/10.3390/pharmaceutics13071091